This syndrome occurs because of increased secretion of PTHrP from tumor cells resulting in elevated levels of calcium in serum and increasing cyclic adenosine 3′,5′-monophosphate (cAMP) excretion in urine (42, 43). Here, PTHLH is linked to neoplasm.